Stock exchange release
Free for publication on February 14, 2022 at 4.35 pm (CET+1)
Person subject to the notification requirement
Name: Petri Toljamo
Position: Member of the Board/Deputy member
Issuer: Bittium Oyj
LEI: 743700NFG5W5I59OVX65
Notification type: INITIAL NOTIFICATION
Reference number: 10045/7/6
____________________________________________
Transaction date: February 11, 2022
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009007264
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 4883 Unit price: 5.1 EUR
(2): Volume: 1504 Unit price: 5.1 EUR
(3): Volume: 305 Unit price: 5.1 EUR
(4): Volume: 207 Unit price: 5.1 EUR
(5): Volume: 771 Unit price: 5.1 EUR
(6): Volume: 2444 Unit price: 5.1 EUR
(7): Volume: 359 Unit price: 5.1 EUR
(8): Volume: 39 Unit price: 5.1 EUR
(9): Volume: 800 Unit price: 5.1 EUR
(10): Volume: 850 Unit price: 5.1 EUR
(11): Volume: 801 Unit price: 5.1 EUR
(12): Volume: 540 Unit price: 5.1 EUR
(13): Volume: 300 Unit price: 5.1 EUR
(14): Volume: 11 Unit price: 5.1 EUR
(15): Volume: 2000 Unit price: 5.1 EUR
(16): Volume: 750 Unit price: 5.1 EUR
(17): Volume: 500 Unit price: 5.1 EUR
(18): Volume: 2500 Unit price: 5.1 EUR
(19): Volume: 300 Unit price: 5.1 EUR
(20): Volume: 136 Unit price: 5.1 EUR
Aggregated transactions
Volume: 20000 Volume weighted average price: 5.1 EUR
Oulu, Finland, February 14, 2022
Bittium Corporation
Hannu Huttunen
CEO
Further information
Kari Jokela
CLO
Bittium Corporation
Tel. +358 40 344 3507
Distribution
Nasdaq Helsinki Oy
Main media
Bittium
Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2021 were EUR 86.9 million and operating profit was EUR 3.2 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com
Files
Bittium Corporation: Notification of Manager's Transactions - Toljamo Petri (wkr0006.pdf)
Print this release